2m 2m 2m 2m 2m 2m 2m
ORCHESTRA (OBIO)
NASDAQ
$3.84-$0.07 (-1.84%)
Price as of Jun 03, 2026 7:55 PM EDT- $234.1MMarket Cap
- 20.68%1-Year Change
- BiotechnologyIndustry
ORCHESTRA (OBIO)
$3.84-$0.07 (-1.84%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 32.9M +1,539.45% | 2.0M -27.36% | 2.8M +699.67% | 345,141 +2,056.73% | |
Cost of Revenue | 190,000 -6.86% | 204,000 +9.68% | 186,000 N/A | N/A N/A | |
Gross Profit | 32.7M +1,714.60% | 1.8M -30.03% | 2.6M +645.78% | 345,141 +2,056.73% | |
Sales and Marketing Expense | 26.9M +12.47% | 23.9M +18.13% | 20.3M N/A | N/A N/A | |
Research and Development Expense | -58.2M +35.93% | -42.8M +26.56% | -33.8M N/A | N/A N/A | |
Depreciation and Amortization Expense | 327,000 +6.17% | 308,000 +7.32% | 287,000 N/A | N/A N/A | |
Total Operating Expenses | 85.3M +27.41% | 66.9M +23.35% | 54.3M +1,733.15% | 3.0M +977.42% | |
Operating Profit | -51.8M -19.43% | -64.3M +24.84% | -51.5M +1,572.13% | -3.1M +680.30% | |
Interest Income | -68,000 0.00% | -68,000 +277.78% | -18,000 -105.22% | 345,141 N/A | |
Interest Expense | -1.1M +286.53% | -297,000 -78.79% | -1.4M N/A | N/A N/A | |
Interest Income and Expense and Net | -1.2M +233.15% | -365,000 -74.26% | -1.4M -510.85% | 345,141 N/A | |
Total Nonoperating Income and Expense | -11,000 0.00% | -11,000 -100.29% | 3.8M N/A | N/A N/A | |
Income before Taxes | -53.0M -17.65% | -64.3M +24.84% | -51.5M +1,572.13% | -3.1M +680.30% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | -52.7M -13.64% | -61.0M +24.23% | -49.1M +1,695.90% | -2.7M +622.14% | |
Net Income from Continuing Operations Applicable to Common | -53.0M -13.22% | -61.0M +24.23% | -49.1M +1,695.90% | -2.7M +622.14% | |
Basic EPS and Net Income | -1.11 -33.13% | -1.66 +12.16% | -1.48 +770.59% | -0.17 +750.00% | |
Diluted EPS and Net Income | -1.11 -33.13% | -1.66 +12.16% | -1.48 +770.59% | -0.17 +750.00% | |
Basic Weighted Average Shares | 47.7M +29.67% | 36.8M +10.82% | 33.2M +102.27% | 16.4M -19.68% | |
Diluted Weighted Average Shares | 47.7M +29.67% | 36.8M +10.82% | 33.2M +102.27% | 16.4M -19.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 34.7M +55.83% | 22.3M -27.15% | 30.6M +17,346.24% | 175,161 -90.02% | |
Short-Term Investments | 71.8M +61.21% | 44.6M -21.80% | 57.0M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 106.5M +59.42% | 66.8M -23.67% | 87.5M +49,869.46% | 175,161 -90.02% | |
Total Current Assets | 107.9M +56.01% | 69.2M -22.38% | 89.1M +29,696.14% | 299,079 -83.39% | |
Accumulated Depreciation | 1.6M +25.17% | 1.3M +24.81% | 1.0M N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.7M +23.92% | 1.4M +8.21% | 1.3M N/A | N/A N/A | |
Total Long-Term Assets | 1.7M +23.92% | 1.4M +8.21% | 1.3M -98.11% | 67.8M -57.65% | |
Total Assets | 114.9M +50.78% | 76.2M -20.00% | 95.2M +39.86% | 68.1M -57.93% | |
Income Taxes Payable | 393,000 -29.95% | 561,000 +10.43% | 508,000 N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 16.7M +3.26% | 16.2M +44.60% | 11.2M +542.75% | 1.7M +953.38% | |
Total Long-Term Debt | 14.3M -0.17% | 14.3M +50.60% | 9.5M N/A | N/A N/A | |
Total Long-Term Liabilities | 308,000 +670.00% | 40,000 -79.59% | 196,000 -96.50% | 5.6M N/A | |
Total Liabilities | 51.5M +19.12% | 43.2M +59.06% | 27.2M +269.96% | 7.3M +27.37% | |
Retained Earnings | -362.6M +17.01% | -309.9M +24.52% | -248.9M +3,483.15% | -6.9M +76.16% | |
Total Stockholders Equity | 53.6M +62.54% | 33.0M -51.56% | 68.0M +1,079.79% | -6.9M +76.17% | |
Total Shares Outstanding | 57.0M +49.32% | 38.2M +6.76% | 35.8M +703.99% | 4.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -49.0M -3.15% | -50.6M +9.61% | -46.1M +2,820.73% | -1.6M +479.85% | |
Capital Expenditures | 489,000 +69.20% | 289,000 +270.51% | 78,000 N/A | N/A N/A | |
Cash from Investing Activities | -26.9M -305.83% | 13.1M +22.48% | 10.7M -88.46% | 92.6M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | 20.0M N/A | |
Cash from Financing Activities | 88.3M +202.81% | 29.2M -36.88% | 46.2M +149.91% | -92.6M N/A | |
Financials Ratio | |||||
Gross Margin | 99.42% +10.68% | 89.83% -3.68% | 93.26% N/A | N/A N/A | |
Operating Margin | -157.61% -95.09% | -3,207.03% +71.85% | -1,866.16% +109.10% | -892.47% -63.82% | |
Return on Assets | -55.18% -22.52% | -71.21% +18.36% | -60.16% +2,428.53% | -2.38% +917.71% | |
Return on Equity | -121.81% +0.81% | -120.84% -24.85% | -160.79% -420.00% | 50.25% +397.84% | |
Revenue Growth | 1,539.45% +5,727.66% | -27.36% -103.91% | 699.67% -65.98% | 2,056.73% +1,286.50% | |
Current Ratio | 6.45 +51.07% | 4.27 -46.32% | 7.95 +4,536.09% | 0.17 -98.42% | |
Cash Ratio | 2.07 +50.91% | 1.37 -49.62% | 2.73 +2,612.94% | 0.10 -99.05% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow